Compare BLSH & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLSH | MIR |
|---|---|---|
| Founded | 2020 | 2005 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Machinery/Components |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.7B |
| IPO Year | 2025 | N/A |
| Metric | BLSH | MIR |
|---|---|---|
| Price | $35.86 | $25.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $53.64 | $28.38 |
| AVG Volume (30 Days) | 1.5M | ★ 2.0M |
| Earning Date | 02-05-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $198,801,000.00 | ★ $902,300,000.00 |
| Revenue This Year | $82.57 | $8.75 |
| Revenue Next Year | $36.84 | $23.17 |
| P/E Ratio | ★ N/A | $251.32 |
| Revenue Growth | ★ 125.19 | 7.82 |
| 52 Week Low | $34.25 | $12.00 |
| 52 Week High | $118.00 | $30.28 |
| Indicator | BLSH | MIR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 51.37 |
| Support Level | N/A | $25.73 |
| Resistance Level | N/A | $27.49 |
| Average True Range (ATR) | 0.00 | 1.09 |
| MACD | 0.00 | 0.12 |
| Stochastic Oscillator | 0.00 | 52.03 |
Bullish is an institutionally focused global digital asset platform focused on providing market infrastructure and information services. Its objective is to provide mission critical products and services that are designed to help institutions grow their businesses, empower individual investors, and drive the adoption of stablecoins, digital assets, and blockchain technology. It expanded its product offering to provide trusted insights, authoritative news, data, indices and transparent analysis to the digital assets industry while facilitating partnerships, investment opportunities, and community engagement through its flagship Consensus conference.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.